Eli Lilly sues Houston-based compounding pharmacy over alleged ‘knockoff’ obesity, diabetes drugs

Eli Lilly sues companies selling alternative versions of its weight loss drug

The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of its drug Zepbound.(Image credit: Bloomberg/Bloomberg via Getty Images)

Eli Lilly is stepping up its fight against copycat weight-loss drugs

In its continuing war against copycat drugs, Eli Lilly (LLY) said on Wednesday that it filed suits against four telehealth companies that offer cheaper versions of its blockbuster GLP-1 weight loss drugs Mounjaro and Zepbound.Read more...

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro.

Eli Lilly opens a new legal front in its battle against compounded GLP-1s

Eli Lilly sued four telehealth firms and their affiliates, but it is adopting a new legal strategy in its fight against compounded GLP-1s.

Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs

Pharmaceutical giant Eli Lilly alleges the companies are selling off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.

Empower Pharmacy CEO: Drug advertising contributed to making U.S. 'the largest pharmaceutical market in the world'

Shaun Noorian, CEO of Empower Pharmacy, said that pharmaceutical advertising has shifted decision-making from medical providers to patients. This shift, he noted on a podcast, has contributed to higher drug demand and positioned the U.S. as the largest pharmaceutical market."Pharma was able to convince our legislators that doing commercials letting patients decide pretty much for themselves what's in their best interests," said Noorian. "Now pat…